Vitamin D and COVID-19 infection and mortality in UK Biobank
- PMID: 32851419
- PMCID: PMC7449523
- DOI: 10.1007/s00394-020-02372-4
Vitamin D and COVID-19 infection and mortality in UK Biobank
Abstract
Purpose: Low blood 25-hydroxyvitamin D (25(OH)D) concentration has been proposed as a potential causal factor in COVID-19 risk. We aimed to establish whether baseline serum 25(OH)D concentration was associated with COVID-19 mortality, and inpatient confirmed COVID-19 infection, in UK Biobank participants.
Methods: UK Biobank recruited 502,624 participants aged 37-73 years between 2006 and 2010. Baseline exposure data, including serum 25(OH)D concentration, were linked to COVID-19 mortality. Univariable and multivariable Cox proportional hazards regression analyses were performed for the association between 25(OH)D and COVID-19 death, and Poisson regression analyses for the association between 25(OH)D and severe COVID-19 infection.
Results: Complete data were available for 341,484 UK Biobank participants, of which 656 had inpatient confirmed COVID-19 infection and 203 died of COVID-19 infection. 25(OH)D concentration was associated with severe COVID-19 infection and mortality univariably (mortality per 10 nmol/L 25(OH)D HR 0.92; 95% CI 0.86-0.98; p = 0.016), but not after adjustment for confounders (mortality per 10 nmol/L 25(OH)D HR 0.98; 95% CI = 0.91-1.06; p = 0.696). Vitamin D insufficiency or deficiency was also not independently associated with either COVID-19 infection or linked mortality.
Conclusions: Our findings do not support a potential link between 25(OH)D concentrations and risk of severe COVID-19 infection and mortality. Randomised trials are needed to prove a beneficial role for vitamin D in the prevention of severe COVID-19 reactions or death.
Keywords: COVID-19; Mortality; Vitamin D.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Comment in
-
Prognostic implications of vitamin D in patients with COVID-19.Eur J Nutr. 2021 Feb;60(1):549-550. doi: 10.1007/s00394-020-02429-4. Eur J Nutr. 2021. PMID: 33225401 Free PMC article. No abstract available.
References
-
- The Centre for Evidence-Based Medicine. (2020) Vitamin D: a rapid review of the evidence for treatment or prevention in COVID-19. https://www.cebm.net/covid-19/vitamin-d-a-rapid-review-of-the-evidence-f.... Accessed 26 Jun 2020
-
- NICE. COVID-19 rapid evidence summary:vitamin D for COVID-19. https://www.nice.org.uk/advice/es28/evidence. Accessed 11 Aug 2020.
-
- (2020) Welsh Government. COVID-19 workforce risk assessment tool. https://gov.wales/checkyourrisk. Accessed 11 Aug 2020
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
